1. Home
  2. MNPR vs EB Comparison

MNPR vs EB Comparison

Compare MNPR & EB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$75.05

Market Cap

531.6M

Sector

Health Care

ML Signal

HOLD

Logo Eventbrite Inc.

EB

Eventbrite Inc.

HOLD

Current Price

$4.43

Market Cap

432.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNPR
EB
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
531.6M
432.7M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
MNPR
EB
Price
$75.05
$4.43
Analyst Decision
Strong Buy
Buy
Analyst Count
13
2
Target Price
$97.83
$5.00
AVG Volume (30 Days)
163.8K
2.6M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$294,798,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.00
$1.81
52 Week High
$105.00
$4.44

Technical Indicators

Market Signals
Indicator
MNPR
EB
Relative Strength Index (RSI) 42.10 83.96
Support Level $74.51 $2.44
Resistance Level $79.31 $2.90
Average True Range (ATR) 6.38 0.04
MACD -0.93 0.12
Stochastic Oscillator 6.10 99.50

Price Performance

Historical Comparison
MNPR
EB

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

Share on Social Networks: